CK2-NCoR signaling cascade promotes prostate tumorigenesis
about
Nuclear receptor corepressor complexes in cancer: mechanism, function and regulationCK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target.Targeting chronic lymphocytic leukemia using CIGB-300, a clinical-stage CK2-specific cell-permeable peptide inhibitor.CX4945 suppresses the growth of castration-resistant prostate cancer cells by reducing AR-V7 expression.
P2860
CK2-NCoR signaling cascade promotes prostate tumorigenesis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CK2-NCoR signaling cascade promotes prostate tumorigenesis
@en
CK2-NCoR signaling cascade promotes prostate tumorigenesis.
@nl
type
label
CK2-NCoR signaling cascade promotes prostate tumorigenesis
@en
CK2-NCoR signaling cascade promotes prostate tumorigenesis.
@nl
prefLabel
CK2-NCoR signaling cascade promotes prostate tumorigenesis
@en
CK2-NCoR signaling cascade promotes prostate tumorigenesis.
@nl
P2093
P2860
P356
P1433
P1476
CK2-NCoR signaling cascade promotes prostate tumorigenesis
@en
P2093
Beom Jin Lim
Changsoo Kim
Ho Sung Jang
Ho-Geun Yoon
Hyo-Kyoung Choi
Jung-Yoon Yoo
Kyung-Chul Choi
Kyung-Hee Chun
Soon Won Hong
P2860
P304
P356
10.18632/ONCOTARGET.1020
P407
P577
2013-07-01T00:00:00Z